ROSEMARY ALLEN: Open Payments
NPI 1942785118 · COLUMBUS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,612 in 20 payments from 10 companies in 2025. Trend: 2023 $446 · 2024 $301 · 2025 $1,612
Travel & lodging: $896Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $1,208 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $175 |
| CVRx, Inc. | 1 | $98 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Amgen Inc. | 1 | $14 |
Products named: WATCHMAN Access System, Kerendia, Barostim Neo System, WATCHMAN FLX, PRALUENT, AMVUTTRA, VERQUVO, Rybelsus.
Industry payments across GA — which companies pay providers there.
